Published in

American Association for the Advancement of Science, Science Translational Medicine, 618(13), 2021

DOI: 10.1126/scitranslmed.abd3079

Links

Tools

Export citation

Search in Google Scholar

Truncated titin proteins and titin haploinsufficiency are targets for functional recovery in human cardiomyopathy due to TTN mutations

Journal article published in 2021 by Andrey Fomin ORCID, Anna Gärtner ORCID, Lukas Cyganek ORCID, Malte Tiburcy ORCID, Izabela Tuleta, Luisa Wellers, Lina Folsche ORCID, Anastasia J. Hobbach ORCID, Marion von Frieling-Salewsky, Andreas Unger, Anna Hucke ORCID, Franziska Koser, Astrid Kassner, Katharina Sielemann ORCID, Katrin Streckfuß-Bömeke ORCID and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Stable expression of truncated titin proteins and titin haploinsufficiency characterize TTN cardiomyopathy and represent targets for therapy.